Manufacturers Life Insurance Company, The Humanigen, Inc Transaction History

Manufacturers Life Insurance Company, The

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.76 - $3.33 $34,656 - $65,571	-19,691 Closed	0 $0
Q1 2022 Aug 11, 2023	BUY	$1.81 - $3.97 $35,640 - $78,173	19,691 New	19,691 $59,000
Q1 2022 May 20, 2022	SELL	$1.81 - $3.97 $9,801 - $21,497	-5,415 Reduced 21.57%	19,691 $59,000
Q4 2021 Feb 16, 2022	BUY	$3.66 - $8.22 $5,233 - $11,754	1,430 Added 6.04%	25,106 $93,000
Q3 2021 Nov 12, 2021	SELL	$5.93 - $17.83 $6,297 - $18,935	-1,062 Reduced 4.29%	23,676 $140,000
Q2 2021 Aug 12, 2021	BUY	$13.54 - $22.74 $334,952 - $562,542	24,738 New	24,738 $430,000

558K

Ticker HGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 103,661,000
Description
Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.